Selective Serotonin Reuptake Inhibitors for Stroke Recovery

被引：1

作者：

Hua, Xing ^{[1
]}

Wu, Simiao ^{[1
]}

Legg, Lynn A. ^{[2
]}

Rudberg, Ann-Sofie ^{[3
]}

Hackett, Maree L. ^{[4
]}

Tilney, Russel ^{[5
]}

Lindgren, Linnea ^{[6
]}

Kutlubaev, Mansur A. ^{[7
]}

Hsieh, Cheng-Fang ^{[8
]}

Barugh, Amanda J. ^{[9
]}

Hankey, Graeme J. ^{[10
]}

Lundstrom, Erik ^{[6
]}

Dennis, Martin ^{[11
]}

Mead, Gillian E. ^{[11
]}

机构：

[1] Sichuan Univ, West China Hosp, Dept Neurol, Chengdu, Peoples R China

[2] NHS Greater Glasgow & Clyde Hlth Board, Paisley, Renfrew, Scotland

[3] Karolinska Inst, Dept Clin Sci, Div Neurol, Danderyd Hosp, Stockholm, Sweden

[4] Univ New South Wales, Fac Med, George Inst Global Hlth, Sydney, NSW, Australia

[5] Mater Dei Hosp, Dept Med, Msida, Malta

[6] Uppsala Univ, Dept Med Sci, Neurol, Uppsala, Sweden

[7] Bashkir State Med Univ, Dept Neurol, Ufa, Russia

[8] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung, Taiwan

[9] Univ Edinburgh, Dept Geriatr Med, Edinburgh, Midlothian, Scotland

[10] Univ Western Australia, Fac Hlth & Med Sci, Med Sch, Perth, WA, Australia

[11] Univ Edinburgh, Ctr Clin Brain Sci, Edinburgh, Midlothian, Scotland

来源：

STROKE | 2022年 / 53卷 / 09期

基金：

英国医学研究理事会;

关键词：

depression; meta-analysis; recovery of function; serotonin uptake inhibitors; stroke;

D O I：

10.1161/STROKEAHA.121.038149

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

[No abstract available]

引用

页码：E426 / E428

页数：3

共 50 条

[21] Efficacy and tolerability of selective serotonin reuptake inhibitors on promoting motor recovery after stroke:meta-analysis of randomized controlled trials
Su, Dongyun
Zhang, Yuqing
Wang, Anzi
Shao, Di
Xu, Fenghua
Dong, Meng
Zhao, Libo
Hu, Yang
Luo, Haiyan
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2021, 21 (10) : 1179 - 1189
[22] Effects of tricyclic antidepressants, selective serotonin reuptake inhibitors, and selective serotonin-norepinephrine reuptake inhibitors on the ocular surface
Ismayilov, Ayna Sariyeva
Celikel, Guler
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2023, 86 (05)
[23] Understanding the pharmacogenetics of selective serotonin reuptake inhibitors
Fabbri, Chiara
Minarini, Alessandro
Niitsu, Tomihisa
Serretti, Alessandro
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (08) : 1093 - 1118
[24] Depression, selective serotonin reuptake inhibitors and osteoporosis
Bab I.
Yirmiya R.
Current Osteoporosis Reports, 2010, 8 (4) : 185 - 191
[25] Interactions of Selective Serotonin Reuptake Inhibitors with β-Amyloid
Tin, Gary
Mohamed, Tarek
Shakeri, Arash
Pham, Amy Trinh
Rao, Praveen P. N.
ACS CHEMICAL NEUROSCIENCE, 2019, 10 (01): : 226 - 234
[26] Hyponatremia as a complication of selective serotonin reuptake inhibitors
Wright, Stephanie K.
Schroeter, Stefanie
JOURNAL OF THE AMERICAN ACADEMY OF NURSE PRACTITIONERS, 2008, 20 (01): : 47 - 51
[27] Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors
Compagner, Chad
Lester, Corey
Dorsch, Michael
PHARMACY, 2021, 9 (01)
[28] Selective serotonin reuptake inhibitors in children and adolescents
Diler, RS
Avci, A
SWISS MEDICAL WEEKLY, 2002, 132 (33-34) : 470 - 477
[29] Selective serotonin reuptake inhibitors and congenital malformations
Chambers, Christina
BRITISH MEDICAL JOURNAL, 2009, 339
[30] Selective Serotonin Reuptake Inhibitors and Risk of Noncardioembolic Ischemic Stroke: A Nested Case-Control Study
Alqdwah-Fattouh, Rasha
Rodriguez-Martin, Sara
Barreira-Hernandez, Diana
Izquierdo-Esteban, Laura
Gil, Miguel
Gonzalez-Bermejo, Diana
Fernandez-Anton, Encarnacion
Rodriguez-Miguel, Antonio
Garcia-Lledo, Alberto
Bolumar, Francisco
de Abajo, Francisco J.
STROKE, 2022, 53 (05) : 1560 - 1569

← 1 2 3 4 5 →